SFG
MRVI icon

Steward Financial Group’s Maravai LifeSciences MRVI Stock Holding History

Steward Financial Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+7
New +$77 ﹤0.01% 1466
2023
Q2 		– Sell
-17
Closed – – 788
2023
Q1 		$0 Buy
17
+15
+750% +$215 ﹤0.01% 840
2022
Q4 		$0 Buy
+2
New +$31 ﹤0.01% 712

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Steward Financial Group's MRVI Position: Q3 2023 in Review

Steward Financial Group opened a new position in Maravai LifeSciences (MRVI) in Q3 2023: 7 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1466 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in MRVI as recently as Q1 2023.

Steward Financial Group first reported a position in MRVI in Q4 2022 and has held it in 3 quarters since. 204 funds tracked by Wall St. Rank hold MRVI as of Q3 2023.

  • Steward Financial Group held 7 shares of Maravai LifeSciences worth $0 as of Q3 2023.
  • Maravai LifeSciences was a new Steward Financial Group position in Q3 2023.
  • Maravai LifeSciences made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1466 holding.
  • Steward Financial Group first reported a position in Maravai LifeSciences in Q4 2022 and has held it in 3 quarters since.
  • 204 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.